Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3159)
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$70.24
Total Value
$526.80K
Shares Held After
377,820
% of Holdings
1.9%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
10,000
Price
$70.24
Total Value
$702.40K
Shares Held After
58,555
% of Holdings
14.6%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
94,767
Price
$0.06
Total Value
$5.69K
Shares Held After
590,167
% of Holdings
16.1%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
33,818
Price
$36.44
Total Value
$1.23M
Shares Held After
1,599,154
% of Holdings
2.1%
Roivant Sciences Ltd. (ROIV)
Venker Eric — President&Immunovant CEO
Shares
166,182
Price
$35.63
Total Value
$5.92M
Shares Held After
1,632,972
% of Holdings
9.2%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
46,620
Price
$1.35
Total Value
$62.94K
Shares Held After
735,701
% of Holdings
6.3%
Chemomab Therapeutics Ltd. (CMMB)
Cohen Neil Harris — Director
Shares
1,000
Price
$2.80
Total Value
$2.80K
Shares Held After
33,000
% of Holdings
2.9%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
700
Price
$60.98
Total Value
$42.68K
Shares Held After
2
% of Holdings
99.7%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
6,368
Price
$60.17
Total Value
$383.15K
Shares Held After
702
% of Holdings
90.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
5,000
Price
$68.81
Total Value
$344.05K
Shares Held After
520,000
% of Holdings
1.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
20,113
Price
$68.42
Total Value
$1.38M
Shares Held After
515,000
% of Holdings
3.9%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
10,000
Price
$71.40
Total Value
$713.97K
Shares Held After
494,887
% of Holdings
2.0%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
3,733
Price
$7.01
Total Value
$26.17K
Shares Held After
4,275,693
% of Holdings
0.1%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
3,733
Price
$7.01
Total Value
$26.17K
Shares Held After
4,275,693
% of Holdings
0.1%
Maze Therapeutics, Inc. (MAZE)
Dandekar Atul — CSBO
Shares
7,500
Price
$27.58
Total Value
$206.82K
Shares Held After
26,250
% of Holdings
22.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$524.42
Total Value
$104.88K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
6
Price
$523.42
Total Value
$3.14K
Shares Held After
324,643
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
517
Price
$522.40
Total Value
$270.08K
Shares Held After
324,649
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
286
Price
$521.58
Total Value
$149.17K
Shares Held After
325,166
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
751
Price
$520.30
Total Value
$390.74K
Shares Held After
325,452
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
412
Price
$519.19
Total Value
$213.91K
Shares Held After
326,203
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,346
Price
$518.14
Total Value
$697.42K
Shares Held After
326,615
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,486
Price
$517.11
Total Value
$768.42K
Shares Held After
327,961
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,386
Price
$516.16
Total Value
$1.23M
Shares Held After
329,447
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,630
Price
$515.46
Total Value
$840.20K
Shares Held After
331,833
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$514.26
Total Value
$246.84K
Shares Held After
333,463
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$43.27
Total Value
$64.91K
Shares Held After
116,731
% of Holdings
1.3%
BIOVIE INC. (BIVI)
Chappell Amy Suzon — Director
Shares
727
Price
$2.16
Total Value
$1.57K
Shares Held After
727
% of Holdings
100.0%
BIOVIE INC. (BIVI)
KIM JOANNE WENDY — Chief Financial Officer
Shares
2,500
Price
$2.18
Total Value
$5.45K
Shares Held After
3,441
% of Holdings
72.7%
BIOVIE INC. (BIVI)
Palumbo Joseph M — Chief Medical Officer
Shares
4,843
Price
$2.16
Total Value
$10.46K
Shares Held After
6,036
% of Holdings
80.2%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
128
Price
$61.77
Total Value
$7.91K
Shares Held After
59,745
% of Holdings
0.2%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
13,485
Price
$60.21
Total Value
$811.93K
Shares Held After
59,873
% of Holdings
18.4%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
36,387
Price
$58.64
Total Value
$2.13M
Shares Held After
73,358
% of Holdings
33.2%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
50,000
Price
$0.05
Total Value
$2.50K
Shares Held After
495,400
% of Holdings
10.1%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
78,239
Price
$1.39
Total Value
$108.75K
Shares Held After
689,081
% of Holdings
11.4%
Chemomab Therapeutics Ltd. (CMMB)
Cohen Neil Harris — Director
Shares
1,304
Price
$2.85
Total Value
$3.72K
Shares Held After
34,000
% of Holdings
3.7%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
8,222
Price
$12.01
Total Value
$98.74K
Shares Held After
142,047
% of Holdings
5.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
300
Price
$252.76
Total Value
$75.83K
Shares Held After
65,686
% of Holdings
0.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
9,259
Price
$251.95
Total Value
$2.33M
Shares Held After
65,986
% of Holdings
12.3%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
19,639
Price
$250.60
Total Value
$4.92M
Shares Held After
75,245
% of Holdings
20.7%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
18,113
Price
$250.02
Total Value
$4.53M
Shares Held After
94,884
% of Holdings
16.0%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
11,423
Price
$248.67
Total Value
$2.84M
Shares Held After
112,997
% of Holdings
9.2%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
18,187
Price
$247.86
Total Value
$4.51M
Shares Held After
124,420
% of Holdings
12.8%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
38,922
Price
$7.20
Total Value
$280.24K
Shares Held After
4,279,426
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
38,922
Price
$7.20
Total Value
$280.24K
Shares Held After
4,279,426
% of Holdings
0.9%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
400,000
Price
$4.04
Total Value
$1.62M
Shares Held After
2,033,270
% of Holdings
16.4%
Cogent Biosciences, Inc. (COGT)
Morris Arlene — Director
Shares
3,161
Price
$37.54
Total Value
$118.66K
Shares Held After
0
% of Holdings
100.0%
Cogent Biosciences, Inc. (COGT)
Morris Arlene — Director
Shares
42,349
Price
$37.09
Total Value
$1.57M
Shares Held After
3,161
% of Holdings
93.1%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
2,000
Price
$13.79
Total Value
$27.58K
Shares Held After
11,005
% of Holdings
18.2%
BIOVIE INC. (BIVI)
DO CUONG V — Director
Shares
15,210
Price
$2.08
Total Value
$31.64K
Shares Held After
16,117
% of Holdings
94.4%
Showing 651–700 of 3159 transactions (page 14 of 64)